Publishing research using ab4787? Please let us know so that we can cite the reference in this datasheet.
ab4787 has been referenced in 8 publications.
- Martinez-Soria N et al. The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation. Cancer Cell 34:626-642.e8 (2018). PubMed: 30300583
- Patel H et al. ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Mol Cancer Ther 17:1156-1166 (2018). PubMed: 29545334
- Kong GM et al. Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity. PLoS One 12:e0181601 (2017). PubMed: 28806746
- Narasimha AM et al. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife 3:N/A (2014). PubMed: 24876129
- Labalette C et al. The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation. J Biol Chem 283:15201-15208 (2008). WB ; Mouse . PubMed: 18378678
- Panic L et al. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol Cell Biol 26:8880-91 (2006). WB ; Mouse . PubMed: 17000767
- Nakagawa M et al. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 280:33926-34 (2005). PubMed: 16055435
- Kozar K et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-91 (2004). PubMed: 15315760